Xaar said that Q3 sales segmentation, by application and by geography, was in line with those reported at the half-year and that its full year revenue and profit expectations remained unchanged.

The Cambridge-based inkjet technology firm’s balance sheet at 30 September 2013 included net cash of £56.6m, up from £49.4m at so June 2013 and £28.9m at 31 December 2012.

Meanwhile, the manufacturing expansion plan, announced in the first half of 2013, was said to be on track to deliver the planned increases in capacity during the remainder of 2013 and the first half of 2014.

Xaar will hold a Capital Markets Day for investors and analysts in London on 28 November 2013 to explain how its technology disrupts and adds value in the end markets in which it operates and to highlight the long-term potential of its technology.

Xaar’s share price, which has rocketed more than 215% in the past year on the back of upgrades to its full-year revenue target in April and June, was down 2.4% at the time of writing at 787p.